VC  Capital Royalty

http://www.capitalroyalty.com





     Office Locations:

1050 Walnut Street, Suite 201
Boulder, CO 80302
Phone: 713-209-7350
Fax: 713-209-7351

Get all office locations for this firm with a National Database subscription or New York Database subscription.
 

Stages:

  • Early
  • Growth


 

Industries:

  • Life Sciences & Healthcare
  • Medical Device

  •  

    Description:

    Founded 2004, Capital Royalty (CRG) acquires and manages a portfolio of royalty and revenue interests in the healthcare sector. The firm has more than $3 billion of assets under management across more than 45 portfolio companies. Capital Royalty invests in a broad range of healthcare market segments, including pharmaceuticals, biotechnology products, drug delivery technologies, diagnostics, medical devices and over-the-counter drugs. Capital Royalty targets investments between $20 and $300 million and focuses on products that have been approved by the appropriate regulatory authorities, and are supported by companies with dedicated sales and marketing infrastructures. Charles W. Tate, Chairman and Founding Partner, has over 30 years of private equity, merchant and investment banking experience with investment institutions such as Hicks, Muse, Tate and Furst. The firm has offices in TX, CO, and NY.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription or New York Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription or New York Database subscription.
    Andrei Dorenbaum Executive Director and General Counsel
    Charles Tate Chairman and Founder
    David Carter Managing Director
    Garth Monroe Chief Financial Officer
    Luke C. Duster Managing Director

     

    Portfolio companies include:


      Bioniche Life Sciences
        web link


      Corium International
        web link


      EndoGastric Solutions
        web link


      Exagen Diagnostics
        web link


      Good Start Genetics
        web link


      RainDance Technologies
        web link


      Solta Medical
        web link


      Tandem Diabetes Care
        web link


      TriVascular
        web link


      Valeritas
        web link


     

    Recent News:


      There is no recent news for Capital Royalty.